Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study on Tozorakimab for Adults with Uncontrolled Asthma Using Medium-to-High Dose Inhaled Corticosteroids
FranceStudy on the Effectiveness and Safety of RO7790121 for Patients with Moderate to Severe Crohn's Disease
AustriaStudy on the Effectiveness and Safety of JNJ-77242113 for Patients with Active Psoriatic Arthritis Who Have Previously Used Biologic Treatments
BulgariaStudy on the Effectiveness and Safety of Efgartigimod PH20 SC for Adults with Systemic Sclerosis
BelgiumStudy on Inhaled Molgramostim for Children with Autoimmune Pulmonary Alveolar Proteinosis
GermanyLong-term Safety and Efficacy Study of Etuvetidigene Autotemcel for Patients with Wiskott-Aldrich Syndrome
ItalyStudy on Rituximab for Patients with Rheumatoid Arthritis: Comparing 200 mg and 1g Doses for Maintenance Treatment
FranceStudy on Vedolizumab and Ustekinumab for Patients with Crohn's Disease and Ulcerative Colitis
DenmarkStudy on Obinutuzumab for Patients with Relapsing Granulomatosis with Polyangiitis
FranceStudy of Gefurulimab for Children and Teens with Generalized Myasthenia Gravis
PolandStudy on the Effects and Safety of Ianalumab in Adults with Lupus Nephritis Who Completed Previous Treatment
CzechiaStudy of N-Acetyl-L-Leucine in Patients with Ataxia-Telangiectasia: A Phase III Trial
GermanyThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
